ArticleRheumatology and therapy2023

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.